Peregrine Asset Advisers’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,884
Closed -$1.11M 168
2024
Q1
$1.11M Sell
13,884
-56,369
-80% -$4.31M 0.44% 60
2023
Q4
$5.55M Buy
70,253
+3,296
+5% +$235K 2.69% 5
2023
Q3
$4.67M Buy
+66,957
New +$4.74M 2.43% 11
2021
Q1
Sell
-25,453
Closed -$1.74M 124
2020
Q4
$1.74M Buy
+25,453
New +$1.66M 0.81% 44

Other funds holding CVS

Peregrine Asset Advisers's CVS Position: Q2 2024 in Review

Peregrine Asset Advisers sold out of CVS Health (CVS) in Q2 2024, closing a stake of 13,884 shares — an estimated $1.11M sold.

Peregrine Asset Advisers first reported a position in CVS in Q4 2020 and held it in 4 quarters. The position peaked at $5.55M in Q4 2023. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Peregrine Asset Advisers reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Peregrine Asset Advisers sold 13,884 CVS Health shares in Q2 2024, an estimated $1.11M.
  • Peregrine Asset Advisers first reported a position in CVS Health in Q4 2020 and held it in 4 quarters.
  • Peregrine Asset Advisers's CVS Health position peaked at $5.55M in Q4 2023.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Peregrine Asset Advisers's 13F filing for Q2 2024, filed 9 Aug 2024.